GlassScriptPhysician profile
Christopher S Litts
NPI 1922061282
$1,933.69
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,600 · 2020: $36.00 · 2021: $130 · 2022: $27.92 · 2023: $36.43 · 2024: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $140.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $1,165.35 | 2019 | |
| Skeletal Dynamics INC | $199.30 | 2019 | |
| Axogen | $114.79 | 2021 | |
| Acumed LLC | $100.00 | 2019 | |
| Medical Device Business Services, INC. | $83.77 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $62.62 | 2024 | |
| Depuy Synthes Sales INC. | $51.43 | 2021-2023 | Na |
| Bioventus LLC | $34.99 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Sanofi-Aventis U.S. LLC | $26.82 | 2019-2020 | |
| Amgen INC. | $23.42 | 2019 | |
| Horizon Therapeutics Plc | $22.87 | 2020 | |
| Atricure, INC. | $19.96 | 2024 | |
| Access Pro Medical, LLC | $14.24 | 2022 | |
| Smith+Nephew, INC. | $14.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Litts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.